If the American Society for Reproductive Medicine's recommendations for egg-donor compensation limits have been successful, they violate antitrust law. If they are ineffective, egg donors are not being sufficiently protected against coercion and commodification.
Efforts to meet the demand for organs have long had disproportionate effects on members of particular races, not only because of disparate levels of need for transplants but because of the way our donation system works.